BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
105.56
-3.04 (-2.80%)
At close: Apr 23, 2026, 4:00 PM EDT
105.00
-0.56 (-0.53%)
After-hours: Apr 23, 2026, 7:36 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $26.69 billion as of April 23, 2026. Its market cap has increased by 28.13% in one year.
Market Cap
26.69B
Enterprise Value
10.88B
1-Year Change
28.13%
Ranking
Category
Stock Price
$105.56
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $26.69B, an increase of 791.31%. That is a compound annual growth rate of 39.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 27.46B | 19.97% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alnylam Pharmaceuticals | 41.24B |
| BeOne Medicines AG | 35.27B |
| Insmed | 30.83B |
| Revolution Medicines | 30.76B |
| Royalty Pharma | 29.23B |
| Moderna | 21.65B |
| Roivant Sciences | 20.81B |
| Summit Therapeutics | 19.48B |